IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.413
AS - Asia 19.575
EU - Europa 16.489
SA - Sud America 4.445
AF - Africa 531
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 23
Totale 72.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.914
SG - Singapore 7.135
RU - Federazione Russa 4.956
CN - Cina 4.854
IT - Italia 4.725
BR - Brasile 3.466
VN - Vietnam 2.580
GB - Regno Unito 1.779
HK - Hong Kong 1.404
BD - Bangladesh 1.364
DE - Germania 1.113
CA - Canada 961
FR - Francia 661
FI - Finlandia 537
SE - Svezia 504
UA - Ucraina 471
IE - Irlanda 455
IN - India 430
AR - Argentina 353
MX - Messico 328
TR - Turchia 290
NL - Olanda 288
PL - Polonia 253
ID - Indonesia 229
ES - Italia 197
ZA - Sudafrica 195
IQ - Iraq 181
EC - Ecuador 177
JP - Giappone 172
IL - Israele 171
PK - Pakistan 156
CO - Colombia 116
AT - Austria 108
VE - Venezuela 93
MA - Marocco 86
AE - Emirati Arabi Uniti 82
UZ - Uzbekistan 76
DK - Danimarca 72
LT - Lituania 66
PY - Paraguay 63
CL - Cile 60
EG - Egitto 58
SA - Arabia Saudita 55
MY - Malesia 54
TN - Tunisia 46
PE - Perù 45
KE - Kenya 44
CH - Svizzera 43
PH - Filippine 39
BE - Belgio 36
CR - Costa Rica 36
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
BO - Bolivia 30
AZ - Azerbaigian 29
DZ - Algeria 29
JM - Giamaica 25
RO - Romania 25
GT - Guatemala 24
CZ - Repubblica Ceca 23
HN - Honduras 22
KZ - Kazakistan 22
NP - Nepal 22
DO - Repubblica Dominicana 21
OM - Oman 19
EU - Europa 17
IR - Iran 17
PT - Portogallo 17
TH - Thailandia 17
AL - Albania 16
TW - Taiwan 16
LB - Libano 15
PA - Panama 14
SK - Slovacchia (Repubblica Slovacca) 14
GR - Grecia 13
KR - Corea 13
NI - Nicaragua 13
TT - Trinidad e Tobago 13
AM - Armenia 12
BG - Bulgaria 12
ET - Etiopia 12
KG - Kirghizistan 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
SV - El Salvador 11
GE - Georgia 10
HU - Ungheria 10
RS - Serbia 10
BB - Barbados 9
CI - Costa d'Avorio 9
HR - Croazia 9
LV - Lettonia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
MD - Moldavia 8
NO - Norvegia 8
Totale 72.362
Salva come PNG Salva come JPEG
Città #
Dallas 6.247
Singapore 3.713
San Jose 2.333
Ashburn 2.274
Beijing 1.767
Chicago 1.474
Los Angeles 1.399
Hong Kong 1.326
Moscow 916
Ho Chi Minh City 838
Milan 798
New York 676
Salt Lake City 611
Chandler 562
Southend 543
Buffalo 532
Rome 530
Hanoi 504
Council Bluffs 480
The Dalles 469
Santa Clara 466
Fairfield 462
San Mateo 451
Dublin 446
Houston 412
Wilmington 361
Lauterbourg 360
Woodbridge 360
São Paulo 359
Hefei 354
Tampa 349
Helsinki 334
Cambridge 322
Seattle 316
Elk Grove Village 272
Boardman 258
Portsmouth 242
Falls Church 237
Munich 235
Pisa 225
Orem 218
Warsaw 217
Stevenage 215
Ann Arbor 212
Ottawa 210
Montreal 205
Florence 194
Beauharnois 193
Jacksonville 190
Brooklyn 176
Mexico City 166
London 164
Frankfurt am Main 160
Dearborn 156
Lawrence 155
Istanbul 151
Tel Aviv 148
Tokyo 146
Denver 144
Toronto 140
Sterling 133
Stockholm 130
Lancaster 129
Poplar 128
Atlanta 126
Chennai 126
Johannesburg 124
Amsterdam 123
Phoenix 118
Rio de Janeiro 118
Dong Ket 117
Nuremberg 113
Miami 112
Lappeenranta 107
Da Nang 106
Figino 104
Bologna 103
Columbus 102
Naples 100
Haiphong 98
Boston 96
Belo Horizonte 86
Turin 84
Dulles 79
Manchester 73
San Diego 72
Palermo 71
Biên Hòa 70
Turku 70
San Francisco 68
Genoa 67
Washington 67
Tashkent 66
Ankara 64
Charlotte 64
Mumbai 64
Brasília 61
Detroit 61
Quito 61
Guangzhou 60
Totale 42.094
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.845
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.706
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.581
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 893
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 732
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 619
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 489
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 453
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 446
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 437
A simple echocardiographic score to rule out cardiac amyloidosis 390
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 363
Building medical knowledge from real world registries: The case of heart failure 361
A simple echocardiographic score to rule out cardiac amyloidosis 360
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 358
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 343
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 334
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 333
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 328
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 327
Treating chemoreflex in heart failure: modulation or demolition? 326
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 316
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 315
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 314
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 313
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 309
Eligibility for vericiguat in a real‐world, contemporary heart failure population 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 301
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 300
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 297
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 296
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 295
[Ten perspectives for research and innovation in cardiac amyloidosis] 294
Screening the health status of people working in a university 294
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 294
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 293
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 291
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 290
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 287
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 284
How to take arms against central apneas in heart failure 284
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 284
Sex-related differences in chronic heart failure 281
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 280
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 273
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 271
Cardiac light-chain deposition disease relapsing in the transplanted heart 271
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 269
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 269
Unmet needs in end-of-life care for heart failure patients 268
Atrial amyloidosis: mechanisms and clinical manifestations 263
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 262
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 262
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 262
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 261
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 261
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 261
RNA-targeting and gene editing therapies for transthyretin amyloidosis 259
Valve disease in cardiac amyloidosis: an echocardiographic score 259
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 259
null 258
null 258
Disease features and management of cardiomyopathies in women 257
Biomarkers for the diagnosis and management of heart failure: New frontiers 257
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 254
null 253
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 247
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 247
Assessing cardiac mechanics through left ventricular haemodynamic forces 245
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 245
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 242
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 242
Biomarkers for the diagnosis and management of heart failure 242
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 241
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 240
Cardiac magnetic resonance in patients with muscular dystrophies 240
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 239
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 239
Valvular heart disease in patients with cardiac amyloidosis 238
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 237
Role of Imaging in Cardiomyopathies 236
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 236
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 234
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 234
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 234
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 233
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 232
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 232
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 231
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 230
Cardiac troponins as biomarkers for cardiac disease 230
Cardiovascular disease and COVID-19: les liaisons dangereuses 229
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 228
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 228
Perspectives in noninvasive imaging for chronic coronary syndromes 227
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 225
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 225
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 225
Totale 33.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 357.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 357.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202642.499 2.194 6.182 4.866 5.533 4.011 2.661 4.125 1.997 2.695 2.804 2.770 2.661
2026/2027734 734 0 0 0 0 0 0 0 0 0 0 0
Totale 73.001